Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anne Pham-Huy, Manish Sadarangani, Vivian Huang, Monika Ostensen, Eliana Castillo, Sarah M. Troster, Wendy Vaudry, Geoffrey C. Nguyen & Karina A. Top. (2019) From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert Review of Clinical Immunology 15:3, pages 221-229.
Read now
Read now
Ramazan Idilman & Mutlu Arat. (2011) Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Review of Anti-infective Therapy 9:8, pages 641-652.
Read now
Read now
Articles from other publishers (19)
H. Dele Davies. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
674
678.e3
.
Figen Çakmak, Mustafa Çakan, Ferhat Demir, Hafize Emine Sonmez, Sedat Çakmak, Fatma Gul Demirkan, Şerife Gül Karadağ, Nuray Aktay Ayaz & Betül Sözeri. (2021) Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis. Rheumatology International 42:7, pages 1199-1205.
Crossref
Crossref
Young Chang, Soung Won Jeong & Jae Young Jang. (2022) Hepatitis B Virus Reactivation Associated With Therapeutic Interventions. Frontiers in Medicine 8.
Crossref
Crossref
Mark Robbins & Karen Doucette. 2022. Infectious Complications in Biologic and Targeted Therapies. Infectious Complications in Biologic and Targeted Therapies
431
450
.
Mumtaz A. Munshi, Megan H. Noe, Yvonne E. Chiu & Jenna L. Streicher. (2021) Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents. Pediatric Dermatology 38:5, pages 1040-1046.
Crossref
Crossref
H. Dele Davies. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
651
656.e3
.
H. Dele Davies, Carrie L. Byington, Yvonne A. Maldonado, Elizabeth D. Barnett, Kathryn M. Edwards, Ruth Lynfield, Flor M. Munoz-Rivas, Dawn L. Nolt, Ann-Christine Nyquist, Mobeen H. Rathore, Mark H. Sawyer, William J. Steinbach, Tina Q. Tan & Theoklis E. Zaoutis. (2016) Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children. Pediatrics 138:2.
Crossref
Crossref
Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti & Marcello Govoni. (2016) Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis Care & Research 68:6, pages 738-743.
Crossref
Crossref
Stevan A. Gonzalez & Robert P. Perrillo. 2016. Hepatitis B Virus in Human Diseases. Hepatitis B Virus in Human Diseases
399
431
.
Atsushi Ogata, Takayoshi Morita, Yuji Yoshida & Toshio Tanaka. (2015) Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis. Therapeutic Delivery 6:3, pages 283-295.
Crossref
Crossref
Shunsuke Mori. (2015) Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World Journal of Gastroenterology 21:36, pages 10274.
Crossref
Crossref
Zsófia Simon, Árpád Illés, Zsófia Miltényi, Ferenc Magyari, László Váróczy, Nikolett Péter & Lajos Gergely. (2012) Immunological changes in diffuse large B-cell lymphomas after Rituximab-CHOP treatment: Own data and review of the literature. Orvosi Hetilap 153:42, pages 1658-1666.
Crossref
Crossref
Sarah C Horton, Jackie L Nam & Maya H Buch. (2012) Safety of biologics in rheumatoid arthritis. International Journal of Clinical Rheumatology 7:4, pages 425-451.
Crossref
Crossref
Elena Becerra, Geraldine Cambridge, Inmaculada de la Torre & Maria J Leandro. (2012) Long-term safety of rituximab in patients with rheumatoid arthritis. International Journal of Clinical Rheumatology 7:4, pages 383-390.
Crossref
Crossref
Georgios Germanidis, Prodromos Hytiroglou, Marina Zakalka & Loukas Settas. (2012) Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept. Journal of Hepatology 56:6, pages 1420-1421.
Crossref
Crossref
Daniela Francisci, Flavio Falcinelli, Elisabetta Schiaroli, Monia Capponi, Barbara Belfiori, Enisia Cecchini & Franco Baldelli. (2018) Reactivation of Hepatitis B Virus Replication Due to Cytotoxic Therapy: A Five-Year Prospective Study. Tumori Journal 98:2, pages 220-224.
Crossref
Crossref
B. Terrier, S. Pol, V. Thibault, J.-E. Gottenberg & P. Cacoub. (2012) Prise en charge du risque de réactivation du virus de l’hépatite B chez les patients traités par immunosuppresseurs et immunomodulateurs en médecine interne : données de l’enquête REACTI-B et proposition d’un algorithme de prise en charge. La Revue de Médecine Interne 33:1, pages 4-12.
Crossref
Crossref
Massimo Marignani, Marco Canzoni, Raffaele D'Amelio, Emanuela De Santis, Alessandra Pecchioli & Gianfranco Delle Fave. (2011) Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? NO. European Journal of Internal Medicine 22:6, pages 576-581.
Crossref
Crossref
MASARU KATO, TATSUYA ATSUMI, TAKASHI KURITA, TOSHIO ODANI, YUICHIRO FUJIEDA, KOTARO OTOMO, TETSUYA HORITA, SHINSUKE YASUDA & TAKAO KOIKE. (2011) Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases. The Journal of Rheumatology 38:10, pages 2209-2214.
Crossref
Crossref